» Articles » PMID: 31346092

A Deep Intronic Splice Mutation of Underlies Hyper IgE Syndrome by Negative Dominance

Abstract

Heterozygous in-frame mutations in coding regions of human underlie the only known autosomal dominant form of hyper IgE syndrome (AD HIES). About 5% of familial cases remain unexplained. The mutant proteins are loss-of-function and dominant-negative when tested following overproduction in recipient cells. However, the production of mutant proteins has not been detected and quantified in the cells of heterozygous patients. We report a deep intronic heterozygous mutation, c.1282-89C>T, in 7 relatives with AD HIES. This mutation creates a new exon in the complementary DNA, which, when overexpressed, generates a mutant STAT3 protein (D427ins17) that is loss-of-function and dominant-negative in terms of tyrosine phosphorylation, DNA binding, and transcriptional activity. In immortalized B cells from these patients, the D427ins17 protein was 2 kDa larger and 4-fold less abundant than wild-type STAT3, on mass spectrometry. The patients' primary B and T lymphocytes responded poorly to STAT3-dependent cytokines. These findings are reminiscent of the impaired responses of leukocytes from other patients with AD HIES due to typical 3 coding mutations, providing further evidence for the dominance of the mutant intronic allele. These findings highlight the importance of sequencing introns in patients with HIES without candidate variants in coding regions and essential splice sites. They also show that AD HIES-causing mutant alleles can be dominant-negative even if the encoded protein is produced in significantly smaller amounts than wild-type STAT3.

Citing Articles

Molecular assessment of splicing variants in a cohort of patients with inborn errors of immunity: methodological approach and interpretation remarks.

Miguel Berenguel L, Gianelli C, Matas Perez E, Del Rosal T, Mendez Echevarria A, Robles Marhuenda A Front Immunol. 2025; 15:1499415.

PMID: 39944559 PMC: 11814461. DOI: 10.3389/fimmu.2024.1499415.


Unraveling the unphosphorylated STAT3-unphosphorylated NF-κB pathway in loss of function STAT3 Hyper IgE syndrome.

Karim A, Garg R, Saikia B, Tiwari A, Sahu S, Malhotra M Front Immunol. 2024; 15:1332817.

PMID: 39229272 PMC: 11369709. DOI: 10.3389/fimmu.2024.1332817.


The complementary roles of STAT3 and STAT1 in cancer biology: insights into tumor pathogenesis and therapeutic strategies.

Wang W, Lopez McDonald M, Kim C, Ma M, Pan Z, Kaufmann C Front Immunol. 2023; 14:1265818.

PMID: 38022653 PMC: 10663227. DOI: 10.3389/fimmu.2023.1265818.


Transcription factor defects in inborn errors of immunity with atopy.

Vaseghi-Shanjani M, Yousefi P, Sharma M, Samra S, Sifuentes E, Turvey S Front Allergy. 2023; 4:1237852.

PMID: 37727514 PMC: 10505736. DOI: 10.3389/falgy.2023.1237852.


Cellular population dynamics shape the route to human pluripotency.

Panariello F, Gagliano O, Luni C, Grimaldi A, Angiolillo S, Qin W Nat Commun. 2023; 14(1):2829.

PMID: 37198156 PMC: 10192362. DOI: 10.1038/s41467-023-37270-w.


References
1.
Grimbacher B, Holland S, Gallin J, GREENBERG F, Hill S, Malech H . Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med. 1999; 340(9):692-702. DOI: 10.1056/NEJM199903043400904. View

2.
Gennery A, Flood T, Abinun M, Cant A . Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant. 2000; 25(12):1303-5. DOI: 10.1038/sj.bmt.1702446. View

3.
Pertea M, Lin X, Salzberg S . GeneSplicer: a new computational method for splice site prediction. Nucleic Acids Res. 2001; 29(5):1185-90. PMC: 29713. DOI: 10.1093/nar/29.5.1185. View

4.
Cartegni L, Wang J, Zhu Z, Zhang M, Krainer A . ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res. 2003; 31(13):3568-71. PMC: 169022. DOI: 10.1093/nar/gkg616. View

5.
Maritano D, Sugrue M, Tininini S, Dewilde S, Strobl B, Fu X . The STAT3 isoforms alpha and beta have unique and specific functions. Nat Immunol. 2004; 5(4):401-9. DOI: 10.1038/ni1052. View